There is no base to this being done. What they are doing is starting phase 2 and phase 3 trials on vaccines that haven’t survived phase 1, yet. Under normal cir

There is no base to this being done. What they are doing is starting phase 2 and phase 3 trials on vaccines that haven’t survived phase 1, yet. Under normal circumstances this would be extremely uneconomical.